Friday, December 22, 2017
Toronto Star-9 hours ago
Tom McAnulty, a pharmacist who formerly worked in the brand-name pharmaceutical industry, said that brand-name companies “detested” Sherman's litigiousness. “Barry was one of the most aggressive,” McAnulty said. “Apotex, they would challenge all sorts of rulings by the government.” But the pair of them personally got ..